Tag: CTA
Methinks expands stroke detection solution into contrast imaging with second US...
Methinks announced today that it has received US Food and Drug Administration (FDA) 510(k) clearance for Methinks computed tomography angiography (CTA) Stroke, an artificial...
RapidAI secures US FDA 510(k) clearance for “groundbreaking” 3D head and...
RapidAI has received US Food and Drug Administration (FDA) 510(k) clearance for Lumina 3D—an “industry-first”, automated 3D imaging reconstruction solution designed to replace manual...
RAPID CTA gets FDA clearance
iSchemaView has received final clearance from the US Food and Drug Administration (FDA) for RAPID CTA, the company’s 3D imaging solution for Computed Tomography...
